Article Details
Retrieved on: 2021-03-03 17:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Toripalimab is the first anti-PD-1 monoclonal antibody developed in China with a BLA submission to the FDA in process. In February 2021, Junshi ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here